Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kash Purohit"'
Autor:
Matthew Winter, Rob Coleman, Jessica Kendall, Carlo Palmieri, Chris Twelves, Sacha Howell, Iain MacPherson, Caroline Wilson, Kash Purohit, Jacqui Gath, Christine Taylor, Richard Eastell, Geraldine Murden, Sarah R. Brown, Emma Rathbone, Janet Brown
Publikováno v:
Journal of Bone Oncology, Vol 35, Iss , Pp 100442- (2022)
Background: Approximately 70% of patients with metastatic breast cancer (MBC) develop bone metastases. Despite advances in systemic treatment options and the use of bone targeted agents in the management of bone metastases to reduce skeletal morbidit
Externí odkaz:
https://doaj.org/article/f4c9910e2ee343c2970db1a4f3955768
Autor:
Boon H Chua, Emma K Link, Ian H Kunkler, Timothy J Whelan, A Helen Westenberg, Guenther Gruber, Guy Bryant, Verity Ahern, Kash Purohit, Peter H Graham, Mohamed Akra, Orla McArdle, Peter O'Brien, Jennifer A Harvey, Carine Kirkove, John H Maduro, Ian D Campbell, Geoff P Delaney, Joseph D Martin, T Trinh T Vu, Thierry M Muanza, Anthony Neal, Ivo A Olivotto
Publikováno v:
The Lancet, 400(10350), 431-440. ELSEVIER SCIENCE INC
2022, ' Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01) : a randomised, factorial, multicentre, open-label, phase 3 study ', The Lancet, vol. 400, no. 10350, pp. 431-440 . https://doi.org/10.1016/S0140-6736(22)01246-6
2022, ' Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01) : a randomised, factorial, multicentre, open-label, phase 3 study ', The Lancet, vol. 400, no. 10350, pp. 431-440 . https://doi.org/10.1016/S0140-6736(22)01246-6
BACKGROUND: Whole breast irradiation (WBI) after conservative surgery for ductal carcinoma in situ (DCIS) reduces local recurrence. We investigated whether a tumour bed boost after WBI improved outcomes, and examined radiation dose fractionation sens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6121677becf3da155cf0d7b923fd3f72
https://doi.org/10.1016/s0140-6736(22)01246-6
https://doi.org/10.1016/s0140-6736(22)01246-6
Autor:
Peter Graham, Mohamed Akra, Emma Link, Boon Chua, Timothy J. Whelan, G. Bryant, Jennifer Harvey, J Ludbrook, Ivo A. Olivotto, Ian Campbell, Guenther Gruber, Kash Purohit, O. McArdle, Geoff P. Delaney, A. Helen Westenberg, Joseph Martin, John H. Maduro, Ian H. Kunkler, Claire Phillips, Verity Ahern, C. Kirkove
Publikováno v:
Olivotto, I A, Link, E, Phillips, C, Whelan, T J, Bryant, G, Kunkler, I, Westenberg, H, Purohit, K, Ahern, V, H. Graham, P, Akra, M, McArdle, O, Ludbrook, J J, Harvey, J A, Maduro, J H, Kirkove, C, Gruber, G, Martin, J D, Campbell, I D & Delaney, G P & Chua, B H 2019, ' International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast ', Radiotherapy and Oncology . https://doi.org/10.1016/j.radonc.2019.07.024
Radiotherapy and Oncology, 142, 180-185. ELSEVIER IRELAND LTD
Radiotherapy and Oncology, 142, 180-185. ELSEVIER IRELAND LTD
Purpose: To assess the cosmetic impact of breast conserving surgery (BCS), whole breast irradiation (WBI) fractionation and tumour bed boost (TBB) use in a phase III trial for women with ductal carcinoma in situ (DCIS) of the breast. Materials and me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68b666fc5cf437a6af83fe7a21bb4447
https://doi.org/10.1016/j.radonc.2019.07.024
https://doi.org/10.1016/j.radonc.2019.07.024
Publikováno v:
Rehabilitation Oncology. 35:188-194
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc44b80000380c9e50cedd570c5063a6
https://doi.org/10.1097/01.reo.0000000000000065
https://doi.org/10.1097/01.reo.0000000000000065
Publikováno v:
Progress in Palliative Care. 4:39-43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93f87af82d51819490765043969cbb9a
https://doi.org/10.1080/09699260.1996.11746735
https://doi.org/10.1080/09699260.1996.11746735
Publikováno v:
Acta Oncologica. 35:23-29
Bisphosphonates, in conjunction with rehydration, are now the treatment of choice for hypercalcaemia of malignancy. They can also relieve bone pain and improve quality of life as single agent therapy and, in conjunction with systemic anticancer treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aad330d66f567d4edb0325cc761c1d3b
https://doi.org/10.3109/02841869609083964
https://doi.org/10.3109/02841869609083964
Autor:
Larry Hayward, Helen Marshall, Peter Simmonds, Om Pra-Kash Purohit, Robert E. Coleman, Anna Waterhouse, R.K. Agrawal, Stephen Houston, Jonathan Wright, Bismark Investigators
Publikováno v:
Journal of Clinical Oncology. 30:511-511
511 Background: Zoledronic acid (ZOL) reduces skeletal morbidity associated with metastatic bone disease by 30-50%. Current recommendations are for indefinite administration of intravenous 3-4 weekly (w) ZOL 4mg. Over recent years it has become clear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a778068c754aeb7efa38443eedc90fa
https://doi.org/10.1200/jco.2012.30.15_suppl.511
https://doi.org/10.1200/jco.2012.30.15_suppl.511
Publikováno v:
Acta Oncologica; 1996, Vol. 35 Issue S5, p23-29, 7p